Literature DB >> 15990566

Longitudinal analysis of CD8 T-cell responses to HIV and hepatitis C virus in a cohort of co-infected haemophiliacs.

Gillian C Harcourt1, Sharyne Donfield, Edward Gomperts, Eric S Daar, Philip Goulder, Rodney E Phillips, Paul Klenerman.   

Abstract

OBJECTIVE: To investigate CD8 T-cell responses to HIV and hepatitis C virus (HCV) over time in a group of co-infected children with haemophilia to assess the influence of the virus infections on each other and on clinical outcome.
DESIGN: The HIV and HCV CD8 T-cell response of HLA-A2 co-infected individuals in the cohort were analysed at two time points, looking at the frequency and phenotype of HIV-specific T cells and assessing overall responses to the two viruses.
METHODS: Peripheral blood mononuclear cells (PBMC) from 72 HLA-A2 co-infected individuals were analysed using an HIV HLA-A2 tetramer and by IFN-gamma ELISpot using a panel of HIV and HCV antigens. PBMC from a group of 26 HLA-A2 HIV mono-infected adults were also analysed as a comparison.
RESULTS: We identified two distinct patterns of response: some patients had a limited response to either virus whilst others made responses to a range of HIV epitopes. HCV responses were detected only in those who made multiple responses to HIV epitopes (P<0.0001). HCV infection had an influence on the phenotype of HIV-specific CD8 T cells, with a reduction in relative perforin and CD57 expression. Lack of functional or tetramer-positive HIV-specific T cells was associated with a decline in absolute CD4 T-cell counts between the time points (up to 7 years; P = 0.005).
CONCLUSION: HCV infection has an impact on the phenotype of HIV-specific CD8 T cells. In this well-defined cohort, failure to maintain effective CD8 T-cell responses against HIV may contribute to disease progression.

Entities:  

Mesh:

Year:  2005        PMID: 15990566     DOI: 10.1097/01.aids.0000176213.10367.05

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  Parasite interactions in natural populations: insights from longitudinal data.

Authors:  S Telfer; R Birtles; M Bennett; X Lambin; S Paterson; M Begon
Journal:  Parasitology       Date:  2008-05-12       Impact factor: 3.234

2.  Diminished frequency of hepatitis C virus specific interferon gamma secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients.

Authors:  G Harcourt; E Gomperts; S Donfield; P Klenerman
Journal:  Gut       Date:  2006-03-16       Impact factor: 23.059

Review 3.  Chronic bystander infections and immunity to unrelated antigens.

Authors:  Erietta Stelekati; E John Wherry
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

4.  Bystander chronic infection negatively impacts development of CD8(+) T cell memory.

Authors:  Erietta Stelekati; Haina Shin; Travis A Doering; Douglas V Dolfi; Carly G Ziegler; Daniel P Beiting; Lucas Dawson; Jennifer Liboon; David Wolski; Mohammed-Alkhatim A Ali; Peter D Katsikis; Hao Shen; David S Roos; W Nicholas Haining; Georg M Lauer; E John Wherry
Journal:  Immunity       Date:  2014-05-15       Impact factor: 31.745

5.  Type I Interferon Elevates Co-Regulatory Receptor Expression on CMV- and EBV-Specific CD8 T Cells in Chronic Hepatitis C.

Authors:  Solomon Owusu Sekyere; Pothakamuri Venkata Suneetha; Svenja Hardtke; Christine Susanne Falk; Julia Hengst; Michael Peter Manns; Markus Cornberg; Heiner Wedemeyer; Verena Schlaphoff
Journal:  Front Immunol       Date:  2015-06-10       Impact factor: 7.561

6.  HIV-Specific CD8(+) T Lymphocytes in Blood of Long-Term HIV-Infected Hemophilia Patients.

Authors:  Volker Daniel; Sabine Scherer; Mahmoud Sadeghi; Peter Terness; Angela Huth-Kühne; Gerhard Opelz
Journal:  Biores Open Access       Date:  2013-12-01

7.  HCV coinfection associated with slower disease progression in HIV-infected former plasma donors naïve to ART.

Authors:  Xiaoyan Zhang; Jianqing Xu; Hong Peng; Yan Ma; Lifeng Han; Yuhua Ruan; Bing Su; Ning Wang; Yiming Shao
Journal:  PLoS One       Date:  2008-12-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.